NCT02509312: A trial that was reported late by University Hospitals Cleveland Medical Center
This trial has reported, although it was 1218 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02509312 |
|---|---|
| Title | A Prospective, Randomized, Control Trial of Ketorolac Versus Placebo on Opioid Analgesic Use, Estimated Blood Loss and Complications Following Cesarean Delivery With Epidural Morphine |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | May 31, 2016 |
| Completion date | Oct. 31, 2017 |
| Required reporting date | Oct. 31, 2018, midnight |
| Actual reporting date | March 2, 2022 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 1218 |